The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence
Open Access
- 1 February 2016
- journal article
- review article
- Published by Taylor & Francis Ltd in Journal of Pain Research
- Vol. ume 9, 67-79
- https://doi.org/10.2147/JPR.S99231
Abstract
The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence Oscar A de León-Casasola,1,2 Victor Mayoral3 1Department of Anesthesiology, Division of Pain Medicine, Roswell Park Cancer Institute, 2University at Buffalo, School of Medicine and Biomedical Sciences. NY, USA; 3Anesthesiology Department, Pain Management Unit, University Hospital of Bellvitge, L'Hospitalet de Llobregat, Spain Topical 5% lidocaine medicated plasters represent a well-established first-line option for the treatment of peripheral localized neuropathic pain (LNP). This review provides an updated overview of the clinical evidence (randomized, controlled, and open-label clinical studies, real-life daily clinical practice, and case series). The 5% lidocaine medicated plaster effectively provides pain relief in postherpetic neuralgia, and data from a large open-label controlled study indicate that the 5% lidocaine medicated plaster is as effective as systemic pregabalin in postherpetic neuralgia and painful diabetic polyneuropathy but with an improved tolerability profile. Additionally, improved analgesia and fewer side effects were experienced by patients treated synchronously with the 5% lidocaine medicated plaster, further demonstrating the value of multimodal analgesia in LNP. The 5% lidocaine medicated plaster provides continued benefit after long-term (≤7 years) use and is also effective in various other LNP conditions. Minor application-site reactions are the most common adverse events associated with the 5% lidocaine medicated plaster; there is minimal risk of systemic adverse events and drug–drug interactions. Although further well-controlled studies are warranted, the 5% lidocaine medicated plaster is efficacious and safe in LNP and may have particular clinical benefit in elderly and/or medically compromised patients because of the low incidence of adverse events. Keywords: 5% lidocaine medicated plaster, clinical evidence, localized neuropathic pain, postherpetic neuralgia, reviewKeywords
This publication has 81 references indexed in Scilit:
- Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic painPain, 2015
- Nocebo vs. Placebo: The Challenges of Trial Design in Analgesia ResearchClinical Pharmacology & Therapeutics, 2015
- [Topical pharmacologic approach with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].2014
- Topical lidocaine for neuropathic pain in adultsPublished by Wiley ,2014
- Therapeutic Effects of Lidocaine Patch on Myofascial Pain Syndrome of the Upper TrapeziusAmerican Journal of Physical Medicine & Rehabilitation, 2012
- New Developments in the Treatment Algorithm for Peripheral Neuropathic PainPain Medicine, 2011
- Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature UpdateMayo Clinic Proceedings, 2010
- Postherpetic neuralgia: Topical lidocaine is effective in nociceptor–deprived skinZeitschrift für Neurologie, 2005
- Myofascial pain response to topical lidocaine patch therapy: case report.2002
- Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment studyPain, 1999